Date: Jun 4, 2018 02:30 PM - 03:30 PM
Registration closes on Jun 04, 2018 10:30 PM
- Describe the evidence for use of direct oral anticoagulants (DOACs) in cancer, kidney disease, and extreme weight patients.
- Identify key practical points for managing VTE in cancer, kidney disease, and extreme weight patients.
- Discuss appropriate care and monitoring plans for these patient populations.
Dhakrit Rungkitwattanakul, Pharm.D., Pharm.D